Volumetric change of human papillomavirus-related neck lymph nodes before, during, and shortly after intensity-modulated radiation therapy

Head and Neck

Volumn 34, Issue 11, 2012, Pages 1640-1647

  Sanguineti, Giuseppe ^a   Ricchetti, Francesco ^a   Wu, Binbin ^a   Agrawal, Nishant ^b   Gourin, Christine ^b   Agbahiwe, Harold ^a   Marur, Shanthi ^c   Clemente, Stefania ^a   McNutt, Todd ^a   Forastiere, Arlene ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

IMRT; lymph nodes; volumetric change

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DENSITY; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LYMPH NODE; MALE; NECK DISSECTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; TREATMENT PLANNING; TREATMENT RESPONSE; TUMOR GROWTH; WART VIRUS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CONE-BEAM COMPUTED TOMOGRAPHY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; RADIOTHERAPY, INTENSITY-MODULATED; TREATMENT OUTCOME;

EID: 84867889859     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21981     Document Type: Article

References (27)

1. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
2. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261-269.
3. Rischin D, Young RJ, Fisher R, et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol 2010; 28: 4142-4148.
4. Gillison ML,. Human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: implications for clinical research in head and neck cancers. J Clin Oncol 2006; 24: 5623-5625.
5. Goldenberg D, Begum S, Westra WH, et al. Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck 2008; 30: 898-903.
6. Munck JN, Cvitkovic E, Piekarski JD, et al. Computed tomographic density of metastatic lymph nodes as a treatment-related prognostic factor in advanced head and neck cancer. J Natl Cancer Inst 1991; 83: 569-575.
7. Bataini JP, Bernier J, Asselain B, et al. Primary radiotherapy of squamous cell carcinoma of the oropharynx and pharyngolarynx: tentative multivariate modelling system to predict the radiocurability of neck nodes. Int J Radiat Oncol Biol Phys 1988; 14: 635-642.
8. Bartelink H,. Prognostic value of the regression rate of neck node metastases during radiotherapy. Int J Radiat Oncol Biol Phys 1983; 9: 993-996.
9. Yang SN, Liao CY, Chen SW, et al. Clinical implications of the tumor volume reduction rate in head-and-neck cancer during definitive intensity-modulated radiotherapy for organ preservation. Int J Radiat Oncol Biol Phys 2011; 79: 1096-1103.
10. Hansen EK, Bucci MK, Quivey JM, Weinberg V, Xia P,. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2006; 64: 355-362.
11. Kuo YC, Wu TH, Chung TS, et al. Effect of regression of enlarged neck lymph nodes on radiation doses received by parotid glands during intensity-modulated radiotherapy for head and neck cancer. Am J Clin Oncol 2006; 29: 600-605.
12. Ojiri H, Mendenhall WM, Stringer SP, Johnson PL, Mancuso AA,. Post-RT CT results as a predictive model for the necessity of planned post-RT neck dissection in patients with cervical metastatic disease from squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2002; 52: 420-428.
13. Westra WH,. The changing face of head and neck cancer in the 21st century: the impact of HPV on the epidemiology and pathology of oral cancer. Head Neck Pathol 2009; 3: 78-81.
14. Sanguineti G, Adapala P, Endres EJ, et al. Dosimetric predictors of laryngeal edema. Int J Radiat Oncol Biol Phys 2007; 68: 741-749.
15. Sanguineti G, Gunn GB, Endres EJ, Chaljub G, Cheruvu P, Parker B,. Patterns of locoregional failure after exclusive IMRT for oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2008; 72: 737-746.
16. Jensen AR, Nellemann HM, Overgaard J,. Tumor progression in waiting time for radiotherapy in head and neck cancer. Radiother Oncol 2007; 84: 5-10.
17. Waaijer A, Terhaard CH, Dehnad H, Hordijk GJ, van Leeuwen MS,. Tumor growth during the waiting period for radiotherapy in patients with oropharyngeal carcinoma. [Article in Dutch] Ned Tijdschr Geneeskd 2003; 147: 1277-1282.
18. Ricchetti F, Wu BB, McNutt T, et al. Volumetric change of selected organs at risk during IMRT for oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2011: 80: 161-168.
19. Hafkamp HC, Mooren JJ, Claessen SM, et al. P21 Cip1/WAF1 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis. Mod Pathol 2009; 22: 686-698.
20. RittàM, De Andrea M, Mondini M, et al. Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progression. Head Neck 2009; 31: 318-327.
21. Barker JL Jr, Garden AS, Ang KK, et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys 2004; 59: 960-970.
22. Bessell EM, Catterall M,. The regression of tumors of the head and neck treated with neutrons. Int J Radiat Oncol Biol Phys 1983; 9: 799-807.
23. Castadot P, Lee JA, Geets X, Grégoire V,. Adaptive radiotherapy of head and neck cancer. Semin Radiat Oncol 2010; 20: 84-93.
24. Pellitteri PK, Ferlito A, Rinaldo A, et al. Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all? Head Neck 2006; 28: 166-175.
25. Porceddu SV, Pryor DI, Burmeister E, et al. Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy. Head Neck 2011 [Epub ahead of print].
26. Moeller BJ, Rana V, Cannon BA, et al. Prospective risk-adjusted [18F]fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol 2009; 27: 2509-2515.
27. Gordon AR, Loevner LA, Shukla-Dave A, et al. Intraobserver variability in the MR determination of tumor volume in squamous cell carcinoma of the pharynx. AJNR Am J Neuroradiol 2004; 25: 1092-1098.